Direkt zum Inhalt

Ad hoc announcement pursuant to Art. 53 LR
HBM Healthcare Investments activates share buyback programme


The discount of the share price to the reported net asset value per share (NAV) has widened in recent days to an extent that the Board of Directors and the Management of HBM Healthcare Investments are convinced does not reflect the fundamental development and future prospects of the Company. For this reason, HBM Healthcare Investments has brought forward the publication of the Half-Year Report as at 30 September 2023 by a few days to today. The half-year results and NAV per share of CHF 237.22 as at 30 September 2023, which were already published at the beginning of October, were confirmed.

The Board of Directors and the Management are of the opinion that the carefully assembled portfolio is of high quality and its value potential is currently not adequately reflected in the Company's market capitalisation. The Company will therefore use a portion of the available cash to implement the current share buyback programme.

The share buybacks will be carried out via the second trading line on the SIX Swiss Exchange in compliance with regulatory volume restrictions and within the possibilities of freely available liquidity. Careful management of the available funds will continue to be a high priority in order to secure the financing of the existing portfolio companies and to take advantage of investment opportunities as they arise.

Further information on the share buyback programme can be found on our website at https://www.hbmhealthcare.com/en/investors/information.

For further information, please contact Dr Andreas Wicki on +41 41 710 75 77, or at andreas.wicki@hbmhealthcare.com.